Related Experiment Video
Updated: Sep 9, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Mediators of Racial Disparities in Head and Neck Cancer Survival
Uchechukwu C Megwalu1, Yifei Ma1, Vasu Divi1
1Department of Otolaryngology-Head & Neck Surgery, Stanford University School of Medicine, Stanford, California, USA.
Objective:
To evaluate and quantify the mediation effects of neighborhood socioeconomic status (SES), insurance status, and quality of care on racial disparities in HNC survival.
Methods:
Retrospective cohort study of data from the California Cancer Registry dataset linked with discharge records and hospital characteristics from the California Department of Health Care Access and Information. The study cohort included adult patients with HNC diagnosed between January 1, 2010, and December 31, 2019. Mediators included insurance status, SES, hospital quality, and National Comprehensive Cancer Network (NCCN) guideline-compliant care.
Results:
Black patients (HR 1.14, 95% CI 1.05-1.24) had worse OS compared with White patients after adjusting for demographic, clinical, and treatment factors. SES accounted for 49.0% (95% CI 13.1%-84.8%) of the disparity. Health insurance (commercial: 21.9% (95% CI 12.3%-38.4%), Medicaid: 19.7% (95% CI 10.1%-45.4%)), hospital quality (high-quality: 5.1% (95% CI 2.1%-9.3%), low-quality: 4.9% (95% CI 1.2%-9.8%)), and guideline-compliant care (10.9% (95% CI 3.2%-23.6%)) also mediated the disparity. Asian/Pacific Islander patients (HR 1.26, 95% CI 1.10-1.43) had worse DSS. Health insurance had a small mediation effect (commercial: 3.0% (95% CI 1.0%-6.6%), Medicaid: 5.1% (95% CI 2.1%-8.9%)), while SES, hospital quality, and guideline-compliant care did not.
Conclusions:
SES, insurance status, and quality of care mediate racial disparities in HNC survival. These findings suggest that health system and policy interventions targeting SES, insurance reform, and quality of care may lead to reductions in HNC disparities.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
Cancer Survival Analysis
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Comparing the Survival Analysis of Two or More Groups
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...